We are live on ! Find out more
Royal Bank of Canada

Royal Bank of Canada Portfolio holdings

AUM $570B
1-Year Est. Return 27.57%
 

Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.

This Fund
S&P 500
This Quarter Est. Return
+5.73%
1 Year Est. Return
+27.57%
3 Year Est. Return
+75.99%
5 Year Est. Return
+94.97%
10 Year Est. Return
+325.25%
AUM
$381B
AUM Growth
+$27.2B
Cap. Flow
+$10.3B
Cap. Flow %
2.7%
Top 10 Hldgs %
19.31%
Holding
8,037
New
676
Increased
3,797
Reduced
2,511
Closed
409

Sector Composition

Rank Sector Weight
1 Financials 18.63%
2 Technology 14.62%
3 Industrials 7.94%
4 Healthcare 7.93%
5 Energy 7.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AUGX
7626
DELISTED
Augmedix, Inc. Common Stock
AUGX
$0 ﹤0.01%
+100
New +$346
ALIM
7627
DELISTED
Alimera Sciences
ALIM
$0 ﹤0.01%
+45
New +$103
AAMC
7628
DELISTED
Altisource Asset Management Corp
AAMC
$0 ﹤0.01%
12
-14
-54% -$647
EMFQ
7629
DELISTED
Amplify Emerging Markets FinTech ETF
EMFQ
-600
Closed -$13K
DNA.WS
7630
DELISTED
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
$0 ﹤0.01%
1,260
TLIS
7631
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
$0 ﹤0.01%
10
+2
+25% +$15
ASXC
7632
DELISTED
Asensus Surgical, Inc.
ASXC
$0 ﹤0.01%
309
-773
-71% -$462
ALLG
7633
DELISTED
Allego N.V.
ALLG
$0 ﹤0.01%
78
BTEK
7634
DELISTED
BlackRock Future Tech ETF
BTEK
-50
Closed -$1K
LL
7635
DELISTED
LL Flooring Holdings, Inc.
LL
-6,620
Closed -$25K
CNTG
7636
DELISTED
Centogene N.V. Common Shares
CNTG
-60
Closed
CONN
7637
DELISTED
Conn's Inc.
CONN
-1,304
Closed -$7K
BTCY
7638
DELISTED
Biotricity, Inc. Common Stock
BTCY
-217
Closed -$1K
MAQCW
7639
DELISTED
Maquia Capital Acquisition Corporation Warrant
MAQCW
$0 ﹤0.01%
+356
New +$13
PEGR
7640
DELISTED
Project Energy Reimagined Acquisition Corp. Class A Ordinary Share
PEGR
-9,055
Closed -$92K
AINC
7641
DELISTED
Ashford Inc.
AINC
$0 ﹤0.01%
34
+19
+127% +$200
NEXI
7642
DELISTED
NexImmune, Inc. Common Stock
NEXI
$0 ﹤0.01%
+20
New +$172
GETR
7643
DELISTED
Getaround, Inc.
GETR
$0 ﹤0.01%
300
-2,075
-87% -$901
CSSE
7644
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Class A Common Stock
CSSE
$0 ﹤0.01%
221
-179
-45% -$277
EFTR
7645
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$0 ﹤0.01%
+16
New +$270
TCON
7646
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$0 ﹤0.01%
+14
New +$256
BIOL
7647
DELISTED
Biolase, Inc.
BIOL
$0 ﹤0.01%
1
SCPX
7648
DELISTED
Scorpius Holdings, Inc.
SCPX
0
THMO
7649
DELISTED
ThermoGenesis Holdings, Inc. Common Stock
THMO
$0 ﹤0.01%
20
HLTH
7650
DELISTED
Cue Health Inc. Common Stock
HLTH
$0 ﹤0.01%
407
-6,320
-94% -$5.39K

Similar funds

Royal Bank of Canada's Q2 2023 Portfolio in Review

As of Q2 2023, Royal Bank of Canada held 8,037 positions worth $381B, up 7.7% from $354B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Royal Bank of Canada's Q2 2023 filing shows 676 new, 3,797 increased, 2,511 reduced and 409 closed positions. Its largest new stake was ATS Corp: 3,088,815 shares worth $142M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $815M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Technology and Industrials.

  • Royal Bank of Canada's largest Q2 2023 buy was ATS Corp: 3,088,815 shares worth $142M.
  • Royal Bank of Canada added most to Thermo Fisher Scientific in Q2 2023, an estimated $987M increase.
  • Royal Bank of Canada's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $815M.
  • Royal Bank of Canada fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $150M.
  • Royal Bank of Canada's ten largest holdings make up 19% of its $381B portfolio in Q2 2023.
  • Royal Bank of Canada opened 676 new positions and closed 409 in Q2 2023.
  • Royal Bank of Canada's portfolio value rose 7.7% quarter-over-quarter to $381B.

Based on Royal Bank of Canada's 13F filing for Q2 2023, filed 14 Aug 2023.